Additionally, concurrent radiation therapy with pembrolizumab was performed in 15 patients without unexpected toxicity
Additionally, concurrent radiation therapy with pembrolizumab was performed in 15 patients without unexpected toxicity. unleash restrained T cell mediated anti-tumor reactions thereby. Anti-PD-1/PD-L1 aimed therapies have obtained regulatory authorization in…